ProfileGDS5822 / ILMN_1224505
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 83% 89% 87% 84% 88% 86% 86% 85% 85% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1190.383
GSM1276600PDAC Late Ablation Control 2408.689
GSM1276601PDAC Late Ablation Control 340287
GSM1276602PDAC Late Ablation 1212.584
GSM1276603PDAC Late Ablation 2388.488
GSM1276604PDAC Late Ablation 3308.186
GSM1303940PDAC Late Ablation_anti-CTLA4 1301.786
GSM1303941PDAC Late Ablation_anti-CTLA4 2310.285
GSM1303942PDAC Late Ablation_anti-CTLA4 3319.385